Predictors of Marijuana Relapse in the Human Laboratory: Robust Impact of Tobacco Cigarette Smoking Status

BACKGROUND Few marijuana smokers in treatment achieve sustained abstinence, yet factors contributing to high relapse rates are unknown. METHODS Study 1: data from five inpatient laboratory studies assessing marijuana intoxication, withdrawal, and relapse were combined to assess factors predicting the likelihood and severity of relapse. Daily, nontreatment-seeking marijuana smokers (n = 51; 10 ± 5 marijuana cigarettes/day) were enrolled. Study 2: to isolate the effects of cigarette smoking, marijuana intoxication, withdrawal, and relapse were assessed in daily marijuana and cigarette smokers (n = 15) under two within-subject, counter-balanced conditions: while smoking tobacco cigarettes as usual (SAU), and after at least 5 days without cigarettes (Quit). RESULTS Study 1: 49% of participants relapsed the first day active marijuana became available. Tobacco cigarette smokers (75%), who were not abstaining from cigarettes, were far more likely to relapse than non-cigarette smokers (odds ratio: 19, p < .01). Individuals experiencing more positive subjective effects (i.e., feeling "high") after marijuana administration and those with more negative affect and sleep disruption during marijuana withdrawal were more likely to have severe relapse episodes (p < .05). Study 2: most participants (>87%) relapsed to marijuana whether in the SAU or Quit phase. Tobacco cigarette smoking did not significantly influence relapse, nor did it affect marijuana intoxication or most symptoms of withdrawal relative to tobacco cessation. CONCLUSIONS Daily marijuana smokers who also smoke cigarettes have high rates of marijuana relapse, and cigarette smoking versus recent abstinence does not directly influence this association. These data indicate that current cigarette smoking is a clinically important marker for increased risk of marijuana relapse.

[1]  Richard A. Brown,et al.  A prospective examination of distress tolerance and early smoking lapse in adult self-quitters. , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[2]  R. Wightman,et al.  Cannabinoids Enhance Subsecond Dopamine Release in the Nucleus Accumbens of Awake Rats , 2004, The Journal of Neuroscience.

[3]  R. Stephens,et al.  Comparison of extended versus brief treatments for marijuana use. , 2000, Journal of consulting and clinical psychology.

[4]  R. Niaura,et al.  Adolescent tobacco use and substance abuse treatment outcomes. , 2009, Journal of substance abuse treatment.

[5]  S. File,et al.  Nicotine and cannabinoids: Parallels, contrasts and interactions , 2006, Neuroscience & Biobehavioral Reviews.

[6]  J. Anthony,et al.  Marijuana use and cessation of tobacco smoking in adults from a community sample. , 2002, Drug and alcohol dependence.

[7]  R. Stephens,et al.  A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. , 2001, Journal of substance abuse treatment.

[8]  S. Gulliver,et al.  Smoking Cessation and Alcohol Abstinence: What Do the Data Tell Us? , 2006, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[9]  W. Velicer,et al.  Biochemical verification of tobacco use and cessation. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[10]  Margaret Haney,et al.  Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans. , 2002, Psychopharmacology.

[11]  Bruce D. Johnson,et al.  Smoking tobacco along with marijuana increases symptoms of cannabis dependence. , 2008, Drug and alcohol dependence.

[12]  R. Boellaard,et al.  Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum , 2009, Neuropsychopharmacology.

[13]  J. Hughes The hardening hypothesis: is the ability to quit decreasing due to increasing nicotine dependence? A review and commentary. , 2011, Drug and alcohol dependence.

[14]  R. Spealman,et al.  Controversies in translational research: drug self-administration , 2008, Psychopharmacology.

[15]  N. Petry,et al.  Abstinence rates following behavioral treatments for marijuana dependence. , 2007, Addictive behaviors.

[16]  D. Riemann,et al.  Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. , 2008, Sleep medicine reviews.

[17]  S. Hall,et al.  A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. , 2004, Journal of consulting and clinical psychology.

[18]  J. Tsoh,et al.  Changes in smoking status among substance abusers: baseline characteristics and abstinence from alcohol and drugs at 12-month follow-up. , 2003, Drug and alcohol dependence.

[19]  M. Jarvik,et al.  Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. , 2000, Experimental and clinical psychopharmacology.

[20]  J. Hughes,et al.  Effects of abstinence from tobacco: valid symptoms and time course. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[21]  M. Haney Self‐administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls , 2009, Addiction biology.

[22]  D. Penetar,et al.  Transdermal nicotine alters some of marihuana's effects in male and female volunteers. , 2005, Drug and alcohol dependence.

[23]  E. Kandel,et al.  Molecular Mechanism for a Gateway Drug: Epigenetic Changes Initiated by Nicotine Prime Gene Expression by Cocaine , 2011, Science Translational Medicine.

[24]  C. Hart,et al.  Nefazodone decreases anxiety during marijuana withdrawal in humans , 2002, Psychopharmacology.

[25]  S. Vosburg,et al.  Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex , 2004, Neuropsychopharmacology.

[26]  Richard W. Foltin,et al.  Comparison of smoked marijuana and oral Δ9-tetrahydrocannabinol in humans , 2002, Psychopharmacology.

[27]  K. Carroll,et al.  Brief treatments for cannabis dependence: findings from a randomized multisite trial. , 2004, Journal of consulting and clinical psychology.

[28]  Jesse Dallery,et al.  Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement , 2007, Psychopharmacology.

[29]  J. Zacny,et al.  The role of human drug self-administration procedures in the development of medications. , 2008, Drug and alcohol dependence.

[30]  G. Pearlson,et al.  Marijuana and cocaine interactions in humans: Cardiovascular consequences , 1987, Pharmacology Biochemistry and Behavior.

[31]  M. Pavlicova,et al.  Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. , 2011, Drug and alcohol dependence.

[32]  S. Higgins,et al.  Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. , 2006, Journal of consulting and clinical psychology.

[33]  G. Patton,et al.  Consequences of youth tobacco use: a review of prospective behavioural studies. , 2006, Addiction.

[34]  M. Jarvik,et al.  Contingency management for tobacco smoking in methadone-maintained opiate addicts. , 1996, Addictive behaviors.

[35]  Richard W. Foltin,et al.  Abstinence symptoms following smoked marijuana in humans , 1999, Psychopharmacology.

[36]  M. Haney,et al.  Effect of Fluoxetine on Food Intake of Humans Living in a Residential Laboratory , 1996, Appetite.

[37]  S. Vosburg,et al.  Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse , 2010, Psychopharmacology.

[38]  Comparison of extended versus brief treatments for marijuana use. , 2000 .

[39]  A. Budney,et al.  Tobacco smoking in marijuana-dependent outpatients. , 2001, Journal of substance abuse.

[40]  W. Fratta,et al.  Cannabinoid self-administration increases dopamine release in the nucleus accumbens , 2006, Neuroreport.

[41]  K. Kendler,et al.  Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. , 2007, Archives of general psychiatry.

[42]  J. Hughes,et al.  A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. , 2008, Drug and alcohol dependence.

[43]  B. Grant,et al.  Cannabis use disorders in the USA: prevalence, correlates and co-morbidity , 2006, Psychological Medicine.

[44]  S. Vosburg,et al.  A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers , 2013, Addiction biology.

[45]  S. Vosburg,et al.  Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse , 2008, Psychopharmacology.

[46]  R. Murray,et al.  Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study , 2011, Journal of psychopharmacology.

[47]  S. Goldberg,et al.  Cannabinoids: reward, dependence, and underlying neurochemical mechanisms—a review of recent preclinical data , 2003, Psychopharmacology.

[48]  Judith J Prochaska,et al.  Drug and Alcohol , 2010 .

[49]  C. Kahler,et al.  Marijuana use and tobacco smoking cessation among heavy alcohol drinkers. , 2011, Drug and alcohol dependence.

[50]  A. Odum,et al.  Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers , 1999, Psychopharmacology.

[51]  N. Rigotti,et al.  US college students' use of tobacco products: results of a national survey. , 2000, JAMA.

[52]  W. Hall The Mental Health Risks of Adolescent Cannabis Use , 2006, PLoS medicine.

[53]  J. Hughes,et al.  Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. , 2007, Drug and alcohol dependence.

[54]  Matthijs G. Bossong,et al.  Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum , 2008, NeuroImage.

[55]  Gerome Breen,et al.  Can recreational doses of THC produce significant dopamine release in the human striatum? , 2009, NeuroImage.